Medtronic Minimed, Inc.

This study checks if a new insulin pump (NMX8) is safe when used with a continuous glucose monitor in people with type 1 or type 2 diabetes. About 400 participants aged 7 to 85 will use their usual therapy with the sensor for up to 40 days, then use the new pump for 90 days. The …

This study tests a new implantable insulin pump (MIIPS 2020) in 40 adults with type 1 diabetes whose blood sugar is hard to control with standard insulin shots or external pumps. The pump is placed inside the body and delivers insulin directly, aiming to reduce dangerous high and…

This study checks if the sticky part of a new patch pump (MiniMed Fit) stays on the skin for up to 7 days. About 175 adults with diabetes who need insulin will wear the patch in different spots. The goal is to see how often the adhesive works well to help design a better future p…